Mrsa reagents
Ended Awarded Last action
- Contract number
- 36C25919N0100
- Awardee
-
Cepheid UEI W6HQTMWB9Q28 Part of Danaher Corporation
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $546,934
Award facts
- Contract value 4% obligated
-
- $1,639,278.94 Current, with exercised options
- $13,255,076.99 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,066 | |
| Supplemental Agreement for work within scope | $150,000 | |
| Original award | $400,000 |
About this award
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for the provision of MRSA reagents under a Blanket Purchase Agreement (BPA) call, with a potential value of $13,255,076.99 and a completion date of September 30, 2021. The contract was awarded on October 1, 2018 and falls under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits. As the original equipment manufacturer, Cepheid provides a range of diagnostic testing products and associated services to various federal agencies, including the VA, the Defense Logistics Agency, and the Department of Health and Human Services. This award does not have a set-aside designation.
Quick answers
Who was awarded contract 36C25919N0100?
36C25919N0100 was awarded to Cepheid by Veterans Integrated Service Network 19 (Veterans Health Administration) on October 1, 2018.
How much is contract 36C25919N0100 worth?
The government has obligated $546,934 on 36C25919N0100. Its current value, with exercised options, is $1,639,279. Its potential value, with all options, is $13,255,077.
Is contract 36C25919N0100 an order under another contract?
Yes. 36C25919N0100 is a BPA call under V797P5967X-VA25915A0099, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25919N0100 competed?
The extent of competition for 36C25919N0100 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award